Market Overview

The diabetes market in the Middle East and Africa was estimated to be worth USD 1.1 billion in 2022. The Middle East and Africa Diabetes market is expected to increase from USD 1.17 billion in 2023 to USD 2.005 billion by 2032, with a compound yearly growth rate (CAGR) of 6.90% during the forecast period (2023-2032). The Indian diabetes market is being pushed by rising obesity and comorbidities, changing lifestyles, increased knowledge of food and lifestyle adjustments, and a growing number of patients with type 2 diabetes mellitus (T2DM) in the country.India shares borders with six countries: Afghanistan, China, Pakistan, Nepal, Bangladesh, and Sri Lanka. This provides easy access to foreign markets via these countries.

The Diabetes Market continues to grow, fueled by rising awareness and prevalence of diabetes symptoms such as increased thirst and frequent urination. With a focus on early detection and management, pharmaceutical companies are developing innovative treatments and technologies. Lifestyle interventions and glucose monitoring devices are also driving market expansion, aiming for improved patient outcomes.

Diabetes prevalence in India is projected to reach 68 million by 2025. Diabetes is on the rise in India due to the country's growing population and increased consumption of processed foods high in sugar and saturated fat. There is solid evidence that diabetes increases the chance of heart attack and stroke, which can damage blood vessels and result in leg amputations and blindness. The growing number of cases is driving up India's prices.

Market Segmentation

The market can be divided into Type 1, Type 2 and Gestational Diabetes based on the variations of the disorder. Depending on the blood sugar diagnosis conducted to detect the condition, the market is segregated into four categories of tests:

• Random blood sugar test
• Fasting blood sugar test
• Oral glucose tolerance test
• Initial glucose challenge test

Based on the types of devices that can be marketed, the market has been categorised into :

• Blood glucose monitoring devices
• Diabetes management devices     

Based on the available treatments, the market has four divisions:

• Medications
• Insulin Therapy
• Transplantation
• Bariatric Surgery

North America, APAC, Europe, and Rest Of the World are the regions in which the market has been split.

Regional Classification

The Diabetes Market report has been prepared based on the data collected from various industry-leading sources. The World Trade Organisation (WTO) acknowledges India as a member. India has also achieved 10th rank among BRICS nations since 2011, with an annual growth rate of 7% in real GDP and 8.1% in real per capita income. India ranked 24th among 188 countries for its Human Development Index score in 2016. The HDI value is 0.636, which is medium human development which is below the high human development category of 1 (most developed).

For more information visit at MarketResearchFuture